Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

MEC Plus Full List View

By pinki@katapult.biz / February 16, 2025

MEC Plus

Speciality

Author / Speaker

Title

Type of Media

Events

Search Everything

«
1
…
15
16
17
18
19
…
96
»

Master Lecture on Small Cell: The Updates

Master Lecture on Small Cell: The Updates

Michael J. Grant, MD

Novel Advances and Updates in the Treatment of Colorectal Cancer

Novel Advances and Updates in the Treatment of Colorectal Cancer

Cathy Eng, MD, FACP, FASCO

Master Lecture on Advances in Pancreatic and Biliary Tract Carcinomas

Master Lecture on Advances in Pancreatic and Biliary Tract Carcinomas

Caio Max Rocha-Lima, MD, MS

Masters Lecture on Best Neoadjuvant Approaches for Rectal Cancer

Masters Lecture on Best Neoadjuvant Approaches for Rectal Cancer

Mike Cusnir, MD

Masters Debate on: ctDNA in Stage II, Stage III, and Post Resection of Oligometastatic Disease (Part 2)

Masters Debate on: ctDNA in Stage II, Stage III, and Post Resection of Oligometastatic Disease (Part 2)

Mike Cusnir, MD

Masters Debate on: ctDNA in Stage II, Stage III, and Post Resection of Oligometastatic Disease (Part 1)

Masters Debate on: ctDNA in Stage II, Stage III, and Post Resection of Oligometastatic Disease (Part 1)

Caio Max Rocha-Lima, MD, MS

Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 2)

Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 2)

Joshua Reuss,MD

Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 1)

Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 1)

Janakiram Subramanian, MD

Master Lecture on Kidney and Bladder Cancer

Master Lecture on Kidney and Bladder Cancer

Ulka Vaishampayan, MD

Master Lecture on Prostate Cancer: Targeted Therapy PSMA and More

Master Lecture on Prostate Cancer: Targeted Therapy PSMA and More

Marc Matrana, MD, MS, FACP

Master Lecture on Ovarian, Fallopian Tube and Uterine Carcinomas

Master Lecture on Ovarian, Fallopian Tube and Uterine Carcinomas

Amanda Nickles Fader, MD

Master Lecture on Triple Negative Breast Cancer

Master Lecture on Triple Negative Breast Cancer

Mark Pegram, MD

Master Lecture on Endocrine Therapy in Early/Advanced Breast Cancer

Master Lecture on Endocrine Therapy in Early/Advanced Breast Cancer

Ricardo H. Alvarez, MD, MsC

Master Lecture on HER-2 in Breast Cancer

Master Lecture on HER-2 in Breast Cancer

Ragisha Gopalakrishnan, MD

Efforts to Overcome Resistance to First Line Immunotherapy

Efforts to Overcome Resistance to First Line Immunotherapy

Hossein Borghaei, DO, MS

Immunotherapy in Metastatic NSCLC: How to Choose Initial Therapy and What’s New?

Immunotherapy in Metastatic NSCLC: How to Choose Initial Therapy and What’s New?

Tina Cascone, MD, PhD

Antibody Drug Conjugates in NSCLC

Antibody Drug Conjugates in NSCLC

Marina Garassino, MD

KRAS and EGFR Exon 20 Insertion

KRAS and EGFR Exon 20 Insertion

Erminia Massarelli, MD, PhD, MS

MET, RAF and NTRK

MET, RAF and NTRK

Pedro Solivan, MD

ALK, ROS-1 and RET

ALK, ROS-1 and RET

Martin Dietrich, MD, PhD

EGFR and Resistant Mechanisms

EGFR and Resistant Mechanisms

Edgardo S. Santos, MD, FACP, FASCO

Immunotherapy in Kidney and Bladder Carcinomas

Immunotherapy in Kidney and Bladder Carcinomas

Jorge A. Garcia, MD, FACP

Targeted Therapy in Sarcomas Beyond GIST

Targeted Therapy in Sarcomas Beyond GIST

Gina D’Amato, MD

Targeted Therapy for Ovarian and Uterine Tumors

Targeted Therapy for Ovarian and Uterine Tumors

Nathalie D. McKenzie, MD, MSPH, DipABLM

Brain Tumors: Is Time for Personalized Medicine?

Brain Tumors: Is Time for Personalized Medicine?

Rimas V. Lukas, MD

Developing Targeted Therapy for Genito-Urinary Malignancies

Developing Targeted Therapy for Genito-Urinary Malignancies

Amanda Nizam MD

Cholangiocarcinoma, Hepatoma and Pancreas: What’s New

Cholangiocarcinoma, Hepatoma and Pancreas: What’s New

Mike Cusnir, MD

Novel Advances in Colorectal Cancer Other Than Immunotherapy

Novel Advances in Colorectal Cancer Other Than Immunotherapy

Cathy Eng, MD, FACP, FASCO

Developments in Esophageal and Gastric Tumors

Developments in Esophageal and Gastric Tumors

Richard Kim, MD

Immunotherapy and Exciting Updates in Advanced Prostate Cancer

Immunotherapy and Exciting Updates in Advanced Prostate Cancer

Natalie Reizine, MD

Displaying 481 - 510 of 2,875

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Useful Links

Library
Live Events

Categories

MEC Basic
MEC Plus
Purchased

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok